| 101 |
20851778 | Binding of huperzine A and galanthamine to acetylcholinesterase, based on ONIOM method. | 2011 Feb |
4 |
| 102 |
20880294 | Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease. | 2011 Aug |
2 |
| 103 |
21168544 | Ion mobility spectrometry: a valuable tool for kinetic studies in enzymology. | 2011 Jan 24 |
2 |
| 104 |
21594999 | Pharmaco-genetically guided treatment of recurrent rage outbursts in an adult male with 15q13.3 deletion syndrome. | 2011 Apr |
2 |
| 105 |
21621811 | Synthesis and biological activity of derivatives of tetrahydroacridine as acetylcholinesterase inhibitors. | 2011 Aug |
1 |
| 106 |
21707398 | In silico design and search for acetylcholinesterase inhibitors in Alzheimer's disease with a suitable pharmacokinetic profile and low toxicity. | 2011 Jun |
2 |
| 107 |
19969445 | Effect of isoquinoline alkaloids from two Hippeastrum species on in vitro acetylcholinesterase activity. | 2010 Jul |
4 |
| 108 |
20193764 | Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review. | 2010 Jun |
1 |
| 109 |
20452337 | Galangin, a flavonol derived from Rhizoma Alpiniae Officinarum, inhibits acetylcholinesterase activity in vitro. | 2010 Sep 6 |
2 |
| 110 |
20562785 | The dramatic effects of Galantamine in a patient with early-onset Alzheimer's disease. | 2010 Jun |
1 |
| 111 |
20655346 | Protective effects of galantamine against Abeta-induced PC12 cell apoptosis by preventing mitochondrial dysfunction and endoplasmic reticulum stress. | 2010 Nov |
2 |
| 112 |
20737911 | Acetylcholinesterase inhibitory activity of uleine from Himatanthus lancifolius. | 2010 Jul-Aug |
1 |
| 113 |
19103181 | Effects of memantine and galantamine given separately or in association, on memory and hippocampal neuronal loss after transient global cerebral ischemia in gerbils. | 2009 Feb 13 |
1 |
| 114 |
19170055 | Simultaneous determination of galantamine, rivastigmine and NAP 226-90 in plasma by MEKC and its application in Alzheimer's disease. | 2009 Feb |
1 |
| 115 |
19199870 | Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients. | 2009 Feb |
3 |
| 116 |
19596285 | Cholinesterase inhibitory activities of some flavonoid derivatives and chosen xanthone and their molecular docking studies. | 2009 Oct 30 |
1 |
| 117 |
20046396 | The effects of galantamine hydrobromide treatment on dehydroepiandrosterone sulfate and cortisol levels in patients with chronic fatigue syndrome. | 2009 Sep |
1 |
| 118 |
17196712 | Inhibition of acetylcholinesterase in CSF versus brain assessed by 11C-PMP PET in AD patients treated with galantamine. | 2008 Feb |
3 |
| 119 |
17379359 | PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD. | 2008 Aug |
4 |
| 120 |
17986678 | Galantamine for the treatment of cognitive impairments in people with schizophrenia. | 2008 Jan |
1 |
| 121 |
18191456 | Antioxidative properties of galantamine on neuronal damage induced by hydrogen peroxide in SK-N-SH cells. | 2008 Mar |
3 |
| 122 |
18438759 | Analysis of galanthamine-type alkaloids by capillary gas chromatography-mass spectrometry in plants. | 2008 Jul-Aug |
1 |
| 123 |
18550339 | Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia. | 2008 Aug |
1 |
| 124 |
18789720 | Monitoring enzyme reaction and screening of inhibitors of acetylcholinesterase by quantitative matrix-assisted laser desorption/ionization Fourier transform mass spectrometry. | 2008 Dec |
1 |
| 125 |
18803156 | [Galantamine therapy in dementia associated with CADASIL]. | 2008 Sep 16-30 |
1 |
| 126 |
17085051 | Preparation of secolycorines against acetylcholinesterase. | 2007 Jan 15 |
1 |
| 127 |
17374745 | The acetylcholinesterase inhibitor galantamine inhibits d-amphetamine-induced psychotic-like behavior in Cebus monkeys. | 2007 Jun |
2 |
| 128 |
17425139 | Quantitative determination of galantamine in human plasma by sensitive liquid chromatography-tandem mass spectrometry using loratadine as an internal standard. | 2007 Feb |
1 |
| 129 |
17656829 | Beyond in vitro data: a review of in vivo evidence regarding the allosteric potentiating effect of galantamine on nicotinic acetylcholine receptors in Alzheimer's neuropathology. | 2007 Jul |
4 |
| 130 |
17724973 | [Acetylcholinesterase inhibitors for dementia--an update]. | 2007 May 21 |
1 |
| 131 |
17955784 | [Are anti-dementia drugs worthwhile?]. | 2007 Sep 13 |
1 |
| 132 |
18042006 | An update on the pharmacology of galantamine. | 2007 Dec |
2 |
| 133 |
16298243 | Inhibition of hippocampal function in mild cognitive impairment: targeting the cholinergic hypothesis. | 2006 Jan |
1 |
| 134 |
16483771 | Isoquinoline derivatives as potential acetylcholinesterase inhibitors. | 2006 Apr 15 |
1 |
| 135 |
17190371 | Galantamine reduces smoking in alcohol-dependent patients: a randomized, placebo-controlled trial. | 2006 Dec |
1 |
| 136 |
18221196 | Galanthamine, a natural product for the treatment of Alzheimer's disease. | 2006 Jan |
1 |
| 137 |
15818530 | [Cost-effectiveness of galantamine in a german context]. | 2005 Apr |
2 |
| 138 |
15951032 | Galantamine-induced behavioral recovery after sublethal excitotoxic lesions to the rat medial septum. | 2005 Aug 30 |
1 |
| 139 |
16144975 | Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors. | 2005 Dec |
3 |
| 140 |
16601783 | Galantamine antiacetylcholinesterase activity in rat brain influenced by L-carnitine. | 2005 Dec |
4 |
| 141 |
14654102 | Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors. | 2004 Jan |
2 |
| 142 |
15101572 | Treatment of Huntington's disease with galantamine. | 2004 Jan |
1 |
| 143 |
15132713 | Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy. | 2004 |
1 |
| 144 |
15222774 | What are the treatment options for patients with severe Alzheimer's disease? | 2004 |
1 |
| 145 |
15296356 | [Galantamine, an acetylcholinesterase inhibitor with various actions]. | 2004 Jul |
1 |
| 146 |
15304241 | Acetylcholinesterase inhibitors: novel activities of old molecules. | 2004 Oct |
2 |
| 147 |
15380373 | Effect of subchronic galantamine treatment on neuronal nicotinic and muscarinic receptor subtypes in transgenic mice overexpressing human acetylcholinesterase. | 2004 Sep |
1 |
| 148 |
15544502 | An overview of the current and novel drugs for Alzheimer's disease with particular reference to anti-cholinesterase compounds. | 2004 |
1 |
| 149 |
15544504 | Development of bivalent acetylcholinesterase inhibitors as potential therapeutic drugs for Alzheimer's disease. | 2004 |
1 |
| 150 |
15544507 | New classes of AChE inhibitors with additional pharmacological effects of interest for the treatment of Alzheimer's disease. | 2004 |
3 |